CURAIZON:IMPROVING HEALTHCARE, REDUCING COSTS & SAVING LIVES™
Dear reader, Just as my usual practice of bringing valuable and profitable information across your way, let me quickly give you information about this great innovation known as "CURAIZON". Please sit down and relax your nerves as you read. Also, I encourage you not only to read, but also to take an important step as part of this great innovation.
ABOUT CURAIZON
Curaizon™ Curaizon™ is a UK-based company that has developed CuraServe™, a soluton to improve drug adherence and bring game-changing benefts to patents and healthcare providers. Our soluton works with patents, their families and healthcare providers to ensure that patents take their medicatons as prescribed through a series of outreach tools, supported by predictve modeling tools and behavioral analysis, to increase the rate of drug adherence. As our CuraServe™ soluton helps patents, it’s also generatng a vast amount of patent data which is then anonymized and made available through our CuraData™ platorm. Companies, academics and non-profts can access this data by purchasing our CuraTokens™. Curaizon™ is unique because our CuraServe™ soluton generates the informaton that drives the value of our CuraData™ platorm. We’re not simply ofering another way of storing, sharing or mining data. Our data is the frst-of-its-kind insight into real-tme patent behaviour and adherence. Through our collaboratons with research insttutons, natonal health services and biotech companies, we shall create one of the most powerful and valuable data sources in healthcare. We will become a centre for excellence within the community of healthcare and pharmaceutcal industries. Our data and analytcs will fnally give the health and pharmaceutcal industries the tools they have been looking for to bring about the change patents need. Our value-based approach to a simple, accessible, yet valuable exchange of data and analysis will revolutonise the healthcare landscape. Leveraging our contracts with healthcare providers, we can quickly build an ecosystem of mutually benefcial stakeholders within the value chain.
Healthcare is changing forever and Curaizon™ stands at the cutng edge of this transformaton.
Social Benefit
*Better Lives
Curaizon’s™ primary focus is on saving lives while reducing costs and improving patent outcomes. Our CuraServe™ soluton will result in an immediate and measurable improvement in patent lives. By driving higher adherence rates, we reduce episodes of acute illness, hospitalizaton and more serious complicatons such as disability and death. By doing this, we help reduce hospital readmissions by up to 50%, and reduce overall costs and eases the fnancial burden of healthcare providers. Keeping patents healthy and families together is at the core of why we do what we do.
*Better Research
The healthcare analytics market is expected to reach $24.55 billion by 2021 from $7.39 billion in 2016, representng an annual growth rate of 27.1%8 . The next generaton of big data and analysis tools that power Smart Health innovaton will not necessarily be about more research, but beter research data. CuraData™ is at the forefront of this paradigm and, through the democratzaton of our data, we can deliver benefts for every stakeholder. From patent to healthcare provider, analyst to token holders, improved societal outcomes are our primary objectves. Our data solutons will support beter prescripton guidelines, speed up drug development, allow for early interventon by doctors, help develop beter treatments for chronic and long-term diseases, identfy best and worst practces and enable efciency by matching the right drug to the right patent based upon actual results
*Better Healthcare
Curaizon™ can reduce waste and keep patents healthy and out of the hospital. We do this by engaging them as a stakeholder in their own care. As technology plays an ever-greater role in healthcare, patent outcomes, quality of care, efciency and life expectancy will all improve. Every tme that we help a patent take their medicaton, we lower overall healthcare costs and allow patents to lead happier and healthier lives.
Curaizon™ will be a driving force in this mission.
*Money Saved
Reducing waste and lowering healthcare costs is of paramount importance to countries around the world. Relieving pressure on payers and allowing those precious resources to be deployed where it is most needed is an extremely efective way to serve society.
Curaizon is the only company that ofers a complete healthcare ecosystem that supports patents byreducing drug non-adherence. The ecosystem includes CuraServe ™, CuraData ™ and CuraView ™ and helps to lower healthcare costs and advance medical research.
CONCLUSION
At Curaizon™, we believe that our adherence tools, data and analytcs will drive the evoluton of Smart Health solutons within the health and pharmaceutcal industries. pharmaceutcal research, for example, would be transformed from a tme consuming, laborious process into a streamlined, data driven, and efcient one. Primary care has been slow to adopt new technologies but is now embracing the enormous benefts of this revoluton. We believe that patents want to be more involved in their care and that by utlizing their data they can drive the next generation of healthcare for the benefit of everyone.
ABOUT CURAIZON
Curaizon™ Curaizon™ is a UK-based company that has developed CuraServe™, a soluton to improve drug adherence and bring game-changing benefts to patents and healthcare providers. Our soluton works with patents, their families and healthcare providers to ensure that patents take their medicatons as prescribed through a series of outreach tools, supported by predictve modeling tools and behavioral analysis, to increase the rate of drug adherence. As our CuraServe™ soluton helps patents, it’s also generatng a vast amount of patent data which is then anonymized and made available through our CuraData™ platorm. Companies, academics and non-profts can access this data by purchasing our CuraTokens™. Curaizon™ is unique because our CuraServe™ soluton generates the informaton that drives the value of our CuraData™ platorm. We’re not simply ofering another way of storing, sharing or mining data. Our data is the frst-of-its-kind insight into real-tme patent behaviour and adherence. Through our collaboratons with research insttutons, natonal health services and biotech companies, we shall create one of the most powerful and valuable data sources in healthcare. We will become a centre for excellence within the community of healthcare and pharmaceutcal industries. Our data and analytcs will fnally give the health and pharmaceutcal industries the tools they have been looking for to bring about the change patents need. Our value-based approach to a simple, accessible, yet valuable exchange of data and analysis will revolutonise the healthcare landscape. Leveraging our contracts with healthcare providers, we can quickly build an ecosystem of mutually benefcial stakeholders within the value chain.
Healthcare is changing forever and Curaizon™ stands at the cutng edge of this transformaton.
Social Benefit
*Better Lives
Curaizon’s™ primary focus is on saving lives while reducing costs and improving patent outcomes. Our CuraServe™ soluton will result in an immediate and measurable improvement in patent lives. By driving higher adherence rates, we reduce episodes of acute illness, hospitalizaton and more serious complicatons such as disability and death. By doing this, we help reduce hospital readmissions by up to 50%, and reduce overall costs and eases the fnancial burden of healthcare providers. Keeping patents healthy and families together is at the core of why we do what we do.
*Better Research
The healthcare analytics market is expected to reach $24.55 billion by 2021 from $7.39 billion in 2016, representng an annual growth rate of 27.1%8 . The next generaton of big data and analysis tools that power Smart Health innovaton will not necessarily be about more research, but beter research data. CuraData™ is at the forefront of this paradigm and, through the democratzaton of our data, we can deliver benefts for every stakeholder. From patent to healthcare provider, analyst to token holders, improved societal outcomes are our primary objectves. Our data solutons will support beter prescripton guidelines, speed up drug development, allow for early interventon by doctors, help develop beter treatments for chronic and long-term diseases, identfy best and worst practces and enable efciency by matching the right drug to the right patent based upon actual results
*Better Healthcare
Curaizon™ can reduce waste and keep patents healthy and out of the hospital. We do this by engaging them as a stakeholder in their own care. As technology plays an ever-greater role in healthcare, patent outcomes, quality of care, efciency and life expectancy will all improve. Every tme that we help a patent take their medicaton, we lower overall healthcare costs and allow patents to lead happier and healthier lives.
Curaizon™ will be a driving force in this mission.
*Money Saved
Reducing waste and lowering healthcare costs is of paramount importance to countries around the world. Relieving pressure on payers and allowing those precious resources to be deployed where it is most needed is an extremely efective way to serve society.
Curaizon is the only company that ofers a complete healthcare ecosystem that supports patents byreducing drug non-adherence. The ecosystem includes CuraServe ™, CuraData ™ and CuraView ™ and helps to lower healthcare costs and advance medical research.
Curaserve ™
• Communicates with patents using non-intrusive reminders.
• Enables family members to support patents. Support healthcare providers with real view into patent behavior.
Curaview ™
CuraView™ is our high-level reportng and informatcs platorm for health services. This service ofers a view into every patent on an individual basis but can generate powerful reports that identfy problems across a range of patent segments. From drugs to disease, and demographics to mult-morbidity, we are able to give the health service an in-depth overview of the successes and failures that lay within the system. Furthermore, it is able to identfy best and worst practce across the network of doctors, highlightng issues that can be resolved with the correct applicaton of resources that would otherwise be unknowable.
Curadata ™
• Collects unique and valuable data.
• Holds only demographic and adherence data. Patent identifies held by health service.
• Available through CuraToken ™
INFORMATION TOKEN
CuraToken (CTKN), it is a token from the standard 20th on Ethereum, which can be used to access data on medical compliance via the CuraData platform.
CuraToken Pre-Sales: 1 June 2018 – 8 June 2018
CuraToken Public Sales: 8 June 2018 – 8 September 2018
Softcap: 1,000,000 USD
Hardcap: 25,000,000 USD
Coins for sale: 250,000,000
Coin Price: 0.2 USD
Roadmap
TEAM
CONCLUSION
At Curaizon™, we believe that our adherence tools, data and analytcs will drive the evoluton of Smart Health solutons within the health and pharmaceutcal industries. pharmaceutcal research, for example, would be transformed from a tme consuming, laborious process into a streamlined, data driven, and efcient one. Primary care has been slow to adopt new technologies but is now embracing the enormous benefts of this revoluton. We believe that patents want to be more involved in their care and that by utlizing their data they can drive the next generation of healthcare for the benefit of everyone.
For more information,visit the link below:
Website: https://curatoken.curaizon.com/
Twitter: https://twitter.com/curaizon
Comments
Post a Comment